{"id":"https://openalex.org/W2912969574","doi":"https://doi.org/10.3324/haematol.2018.211011","title":"The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models","display_name":"The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models","publication_year":2019,"publication_date":"2019-02-07","ids":{"openalex":"https://openalex.org/W2912969574","doi":"https://doi.org/10.3324/haematol.2018.211011","mag":"2912969574","pmid":"https://pubmed.ncbi.nlm.nih.gov/30733273","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6669148"},"language":"en","primary_location":{"id":"doi:10.3324/haematol.2018.211011","doi":"https://doi.org/10.3324/haematol.2018.211011","is_oa":true,"landing_page_url":"https://doi.org/10.3324/haematol.2018.211011","pdf_url":"https://haematologica.org/article/download/9012/64272","source":{"id":"https://openalex.org/S2752781272","display_name":"Haematologica","issn_l":"0390-6078","issn":["0390-6078","1592-8721"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317774","host_organization_name":"Ferrata Storti Foundation","host_organization_lineage":["https://openalex.org/P4310317774"],"host_organization_lineage_names":["Ferrata Storti Foundation"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haematologica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://haematologica.org/article/download/9012/64272","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001079097","display_name":"Stuart W. Hicks","orcid":"https://orcid.org/0000-0001-6601-4470","observed_orcids":["https://orcid.org/0000-0001-6601-4470"]},"institutions":[{"id":"https://openalex.org/I4210096123","display_name":"ImmunoGen (United States)","ror":"https://ror.org/00scb2f23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210096123"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stuart W. Hicks","raw_affiliation_strings":["ImmunoGen Inc., Waltham, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImmunoGen Inc., Waltham, MA, USA","institution_ids":["https://openalex.org/I4210096123"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064713685","display_name":"Chiara Tarantelli","orcid":"https://orcid.org/0000-0002-4394-7742","observed_orcids":["https://orcid.org/0000-0002-4394-7742"]},"institutions":[{"id":"https://openalex.org/I4210101830","display_name":"Institute of Oncology Research","ror":"https://ror.org/01dpyn972","country_code":"CH","type":"facility","lineage":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]},{"id":"https://openalex.org/I57201433","display_name":"Universit\u00e0 della Svizzera italiana","ror":"https://ror.org/03c4atk17","country_code":"CH","type":"education","lineage":["https://openalex.org/I57201433"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Chiara Tarantelli","raw_affiliation_strings":["Universit\u00e0 della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e0 della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland","institution_ids":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063534351","display_name":"Alan Wilhem","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096123","display_name":"ImmunoGen (United States)","ror":"https://ror.org/00scb2f23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210096123"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan Wilhem","raw_affiliation_strings":["ImmunoGen Inc., Waltham, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImmunoGen Inc., Waltham, MA, USA","institution_ids":["https://openalex.org/I4210096123"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103083472","display_name":"Eugenio Gaudio","orcid":"https://orcid.org/0000-0002-0724-1590","observed_orcids":["https://orcid.org/0000-0002-0724-1590"]},"institutions":[{"id":"https://openalex.org/I4210101830","display_name":"Institute of Oncology Research","ror":"https://ror.org/01dpyn972","country_code":"CH","type":"facility","lineage":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]},{"id":"https://openalex.org/I57201433","display_name":"Universit\u00e0 della Svizzera italiana","ror":"https://ror.org/03c4atk17","country_code":"CH","type":"education","lineage":["https://openalex.org/I57201433"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Eugenio Gaudio","raw_affiliation_strings":["Universit\u00e0 della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e0 della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland","institution_ids":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100643214","display_name":"Min Li","orcid":"https://orcid.org/0000-0003-1350-9909","observed_orcids":["https://orcid.org/0000-0003-1350-9909"]},"institutions":[{"id":"https://openalex.org/I4210096123","display_name":"ImmunoGen (United States)","ror":"https://ror.org/00scb2f23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210096123"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Min Li","raw_affiliation_strings":["ImmunoGen Inc., Waltham, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImmunoGen Inc., Waltham, MA, USA","institution_ids":["https://openalex.org/I4210096123"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007167867","display_name":"Alberto J. Arribas","orcid":"https://orcid.org/0000-0003-3123-6203","observed_orcids":["https://orcid.org/0000-0003-3123-6203","https://orcid.org/0000-0003-4971-9780"]},"institutions":[{"id":"https://openalex.org/I4210101830","display_name":"Institute of Oncology Research","ror":"https://ror.org/01dpyn972","country_code":"CH","type":"facility","lineage":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]},{"id":"https://openalex.org/I57201433","display_name":"Universit\u00e0 della Svizzera italiana","ror":"https://ror.org/03c4atk17","country_code":"CH","type":"education","lineage":["https://openalex.org/I57201433"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Alberto J. Arribas","raw_affiliation_strings":["Universit\u00e0 della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e0 della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland","institution_ids":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038420682","display_name":"Filippo Spriano","orcid":"https://orcid.org/0000-0002-8615-1568","observed_orcids":["https://orcid.org/0000-0002-8615-1568"]},"institutions":[{"id":"https://openalex.org/I4210101830","display_name":"Institute of Oncology Research","ror":"https://ror.org/01dpyn972","country_code":"CH","type":"facility","lineage":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]},{"id":"https://openalex.org/I57201433","display_name":"Universit\u00e0 della Svizzera italiana","ror":"https://ror.org/03c4atk17","country_code":"CH","type":"education","lineage":["https://openalex.org/I57201433"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Filippo Spriano","raw_affiliation_strings":["Universit\u00e0 della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e0 della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland","institution_ids":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112302720","display_name":"Roberta Pittau Bordone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4404532900","display_name":"Istituto Oncologico della Svizzera Italiana","ror":"https://ror.org/04tty5b50","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210095212","https://openalex.org/I4404532900"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Roberta Bordone","raw_affiliation_strings":["Oncology Institute of Southern Switzerland, Bellinzona, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Institute of Southern Switzerland, Bellinzona, Switzerland","institution_ids":["https://openalex.org/I4404532900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012537023","display_name":"Luciano Cascione","orcid":"https://orcid.org/0000-0002-4606-0637","observed_orcids":["https://orcid.org/0000-0002-4606-0637"]},"institutions":[{"id":"https://openalex.org/I12708293","display_name":"SIB Swiss Institute of Bioinformatics","ror":"https://ror.org/002n09z45","country_code":"CH","type":"nonprofit","lineage":["https://openalex.org/I12708293"]},{"id":"https://openalex.org/I4210101830","display_name":"Institute of Oncology Research","ror":"https://ror.org/01dpyn972","country_code":"CH","type":"facility","lineage":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]},{"id":"https://openalex.org/I57201433","display_name":"Universit\u00e0 della Svizzera italiana","ror":"https://ror.org/03c4atk17","country_code":"CH","type":"education","lineage":["https://openalex.org/I57201433"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Luciano Cascione","raw_affiliation_strings":["Swiss Institute of Bioinformatics, Lausanne, Switzerland and","Universit\u00e0 della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Swiss Institute of Bioinformatics, Lausanne, Switzerland and","institution_ids":["https://openalex.org/I12708293"]},{"raw_affiliation_string":"Universit\u00e0 della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland","institution_ids":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086428809","display_name":"Katharine C. Lai","orcid":"https://orcid.org/0000-0003-4842-8041","observed_orcids":["https://orcid.org/0000-0003-4842-8041"]},"institutions":[{"id":"https://openalex.org/I4210096123","display_name":"ImmunoGen (United States)","ror":"https://ror.org/00scb2f23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210096123"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katharine C. Lai","raw_affiliation_strings":["ImmunoGen Inc., Waltham, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImmunoGen Inc., Waltham, MA, USA","institution_ids":["https://openalex.org/I4210096123"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108833595","display_name":"Qifeng Qiu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096123","display_name":"ImmunoGen (United States)","ror":"https://ror.org/00scb2f23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210096123"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qifeng Qiu","raw_affiliation_strings":["ImmunoGen Inc., Waltham, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImmunoGen Inc., Waltham, MA, USA","institution_ids":["https://openalex.org/I4210096123"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034038898","display_name":"Monica Taborelli","orcid":"https://orcid.org/0000-0002-4293-187X","observed_orcids":["https://orcid.org/0000-0002-4293-187X"]},"institutions":[{"id":"https://openalex.org/I4210095212","display_name":"Ente Ospedaliero Cantonale","ror":"https://ror.org/00sh19a92","country_code":"CH","type":"other","lineage":["https://openalex.org/I4210095212"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Monica Taborelli","raw_affiliation_strings":["Cytogenetics Laboratory, Ente Ospedaliero Cantonale, Bellinzona, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cytogenetics Laboratory, Ente Ospedaliero Cantonale, Bellinzona, Switzerland","institution_ids":["https://openalex.org/I4210095212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015790909","display_name":"Davide Rossi","orcid":"https://orcid.org/0000-0002-2837-1597","observed_orcids":["https://orcid.org/0000-0002-2837-1597"]},"institutions":[{"id":"https://openalex.org/I4210101830","display_name":"Institute of Oncology Research","ror":"https://ror.org/01dpyn972","country_code":"CH","type":"facility","lineage":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]},{"id":"https://openalex.org/I4404532900","display_name":"Istituto Oncologico della Svizzera Italiana","ror":"https://ror.org/04tty5b50","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210095212","https://openalex.org/I4404532900"]},{"id":"https://openalex.org/I57201433","display_name":"Universit\u00e0 della Svizzera italiana","ror":"https://ror.org/03c4atk17","country_code":"CH","type":"education","lineage":["https://openalex.org/I57201433"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Davide Rossi","raw_affiliation_strings":["Oncology Institute of Southern Switzerland, Bellinzona, Switzerland","Universit\u00e0 della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Institute of Southern Switzerland, Bellinzona, Switzerland","institution_ids":["https://openalex.org/I4404532900"]},{"raw_affiliation_string":"Universit\u00e0 della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland","institution_ids":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011622095","display_name":"Georg St\u00fcssi","orcid":"https://orcid.org/0000-0002-1667-0637","observed_orcids":["https://orcid.org/0000-0002-1667-0637"]},"institutions":[{"id":"https://openalex.org/I4404532900","display_name":"Istituto Oncologico della Svizzera Italiana","ror":"https://ror.org/04tty5b50","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210095212","https://openalex.org/I4404532900"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Georg Stussi","raw_affiliation_strings":["Oncology Institute of Southern Switzerland, Bellinzona, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Institute of Southern Switzerland, Bellinzona, Switzerland","institution_ids":["https://openalex.org/I4404532900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102763531","display_name":"Emanuele Zucca","orcid":"https://orcid.org/0000-0002-5522-6109","observed_orcids":["https://orcid.org/0000-0002-5522-6109"]},"institutions":[{"id":"https://openalex.org/I4404532900","display_name":"Istituto Oncologico della Svizzera Italiana","ror":"https://ror.org/04tty5b50","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210095212","https://openalex.org/I4404532900"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Emanuele Zucca","raw_affiliation_strings":["Oncology Institute of Southern Switzerland, Bellinzona, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Institute of Southern Switzerland, Bellinzona, Switzerland","institution_ids":["https://openalex.org/I4404532900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048622832","display_name":"Anastasios Stathis","orcid":"https://orcid.org/0000-0002-2859-7529","observed_orcids":["https://orcid.org/0000-0002-2859-7529"]},"institutions":[{"id":"https://openalex.org/I4404532900","display_name":"Istituto Oncologico della Svizzera Italiana","ror":"https://ror.org/04tty5b50","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210095212","https://openalex.org/I4404532900"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Anastasios Stathis","raw_affiliation_strings":["Oncology Institute of Southern Switzerland, Bellinzona, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Institute of Southern Switzerland, Bellinzona, Switzerland","institution_ids":["https://openalex.org/I4404532900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089572805","display_name":"Callum Mortimer Sloss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096123","display_name":"ImmunoGen (United States)","ror":"https://ror.org/00scb2f23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210096123"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Callum M. Sloss","raw_affiliation_strings":["ImmunoGen Inc., Waltham, MA, USA frbertoni@mac.com callum.sloss@immunogen.com","ImmunoGen Inc., Waltham, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImmunoGen Inc., Waltham, MA, USA frbertoni@mac.com callum.sloss@immunogen.com","institution_ids":["https://openalex.org/I4210096123"]},{"raw_affiliation_string":"ImmunoGen Inc., Waltham, MA, USA","institution_ids":["https://openalex.org/I4210096123"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066518317","display_name":"Francesco Bertoni","orcid":"https://orcid.org/0000-0001-5637-8983","observed_orcids":["https://orcid.org/0000-0001-5637-8983","https://orcid.org/0000-0002-7301-1208"]},"institutions":[{"id":"https://openalex.org/I4210101830","display_name":"Institute of Oncology Research","ror":"https://ror.org/01dpyn972","country_code":"CH","type":"facility","lineage":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]},{"id":"https://openalex.org/I57201433","display_name":"Universit\u00e0 della Svizzera italiana","ror":"https://ror.org/03c4atk17","country_code":"CH","type":"education","lineage":["https://openalex.org/I57201433"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Francesco Bertoni","raw_affiliation_strings":["Universit\u00e0 della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland frbertoni@mac.com callum.sloss@immunogen.com","Universit\u00e0 della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e0 della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland frbertoni@mac.com callum.sloss@immunogen.com","institution_ids":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]},{"raw_affiliation_string":"Universit\u00e0 della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland","institution_ids":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5066518317","https://openalex.org/A5089572805"],"corresponding_institution_ids":["https://openalex.org/I4210096123","https://openalex.org/I4210101830","https://openalex.org/I57201433"],"apc_list":{"value":2000,"currency":"EUR","value_usd":2157},"apc_paid":{"value":2000,"currency":"EUR","value_usd":2157},"fwci":5.4119,"has_fulltext":true,"cited_by_count":41,"citation_normalized_percentile":{"value":0.96295963,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"104","issue":"8","first_page":"1633","last_page":"1639"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.4867999851703644,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.4867999851703644,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.35690000653266907,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.07450000196695328,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.8730000257492065},{"id":"https://openalex.org/keywords/cd19","display_name":"CD19","score":0.8809999823570251},{"id":"https://openalex.org/keywords/dna-alkylating-agents","display_name":"DNA alkylating agents","score":0.6859999895095825},{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.9039999842643738},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.9919999837875366},{"id":"https://openalex.org/keywords/b-cell-malignancies","display_name":"B-cell malignancies","score":0.8090000152587891},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.7839999794960022},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.7450000047683716},{"id":"https://openalex.org/keywords/bcl2-translocation","display_name":"BCL2 translocation","score":0.6449999809265137},{"id":"https://openalex.org/keywords/myc-translocation","display_name":"MYC translocation","score":0.9430000185966492},{"id":"https://openalex.org/keywords/p53-inactivation","display_name":"p53 inactivation","score":0.9729999899864197}],"concepts":[{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.8383833169937134},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6525662541389465},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6328856945037842},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.6059980392456055},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5478680729866028},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5348443388938904},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5072636008262634},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.46427127718925476},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.442697674036026},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4396350383758545},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.4264727532863617},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.41393840312957764},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.32126784324645996},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.29074108600616455},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2550666928291321},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24394574761390686},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.048951804637908936},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008453","descriptor_name":"Maytansine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D008453","descriptor_name":"Maytansine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008453","descriptor_name":"Maytansine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D018941","descriptor_name":"Antigens, CD19","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.3324/haematol.2018.211011","doi":"https://doi.org/10.3324/haematol.2018.211011","is_oa":true,"landing_page_url":"https://doi.org/10.3324/haematol.2018.211011","pdf_url":"https://haematologica.org/article/download/9012/64272","source":{"id":"https://openalex.org/S2752781272","display_name":"Haematologica","issn_l":"0390-6078","issn":["0390-6078","1592-8721"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317774","host_organization_name":"Ferrata Storti Foundation","host_organization_lineage":["https://openalex.org/P4310317774"],"host_organization_lineage_names":["Ferrata Storti Foundation"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haematologica","raw_type":"journal-article"},{"id":"pmid:30733273","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30733273","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haematologica","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6669148","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6669148/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haematologica","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:1f3dab50ef484dd68bae9787aaa3453e","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/1f3dab50ef484dd68bae9787aaa3453e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Haematologica, Vol 104, Iss 8 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3324/haematol.2018.211011","doi":"https://doi.org/10.3324/haematol.2018.211011","is_oa":true,"landing_page_url":"https://doi.org/10.3324/haematol.2018.211011","pdf_url":"https://haematologica.org/article/download/9012/64272","source":{"id":"https://openalex.org/S2752781272","display_name":"Haematologica","issn_l":"0390-6078","issn":["0390-6078","1592-8721"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317774","host_organization_name":"Ferrata Storti Foundation","host_organization_lineage":["https://openalex.org/P4310317774"],"host_organization_lineage_names":["Ferrata Storti Foundation"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haematologica","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320318208","display_name":"Fondazione Gelu","ror":"https://ror.org/01j5a9j34"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2912969574.pdf","grobid_xml":"https://content.openalex.org/works/W2912969574.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W1990310737","https://openalex.org/W1998278019","https://openalex.org/W2041142448","https://openalex.org/W2046522614","https://openalex.org/W2065528643","https://openalex.org/W2076131977","https://openalex.org/W2078164350","https://openalex.org/W2095012305","https://openalex.org/W2164337721","https://openalex.org/W2165800290","https://openalex.org/W2169000897","https://openalex.org/W2220679566","https://openalex.org/W2240926661","https://openalex.org/W2262617296","https://openalex.org/W2305782972","https://openalex.org/W2356002586","https://openalex.org/W2395592928","https://openalex.org/W2597045666","https://openalex.org/W2736511490","https://openalex.org/W2754365127","https://openalex.org/W2759003539","https://openalex.org/W2765262832","https://openalex.org/W2768771216","https://openalex.org/W2781525129","https://openalex.org/W2781864644","https://openalex.org/W2790638270","https://openalex.org/W2792232222","https://openalex.org/W2795228956","https://openalex.org/W2795974062","https://openalex.org/W2809013389","https://openalex.org/W2884909078","https://openalex.org/W2891704122","https://openalex.org/W2892984448","https://openalex.org/W2897977935","https://openalex.org/W2899694188","https://openalex.org/W2900510353","https://openalex.org/W2907868160","https://openalex.org/W2908042246","https://openalex.org/W3126564461"],"related_works":["https://openalex.org/W2741351734","https://openalex.org/W2023807748","https://openalex.org/W53326808","https://openalex.org/W2334143821","https://openalex.org/W2884302853","https://openalex.org/W2069832110","https://openalex.org/W2165800290","https://openalex.org/W2587835437","https://openalex.org/W2269383985","https://openalex.org/W4242132448"],"abstract_inverted_index":{"Antibody-drug":[0],"conjugates":[1],"(ADC)":[2],"are":[3],"a":[4,15,34],"novel":[5,35],"way":[6],"to":[7,12,46,62,93],"deliver":[8],"potent":[9,48],"cytotoxic":[10,59],"compounds":[11],"cells":[13],"expressing":[14],"specific":[16],"antigen.":[17],"Four":[18],"ADC":[19,36],"targeting":[20],"CD19,":[21],"including":[22],"SAR3419":[23,40,63],"(coltuximab":[24],"ravtansine),":[25],"have":[26],"entered":[27],"clinical":[28,121],"development.":[29],"Here,":[30],"we":[31],"present":[32],"huB4-DGN462,":[33],"based":[37],"on":[38],"the":[39,47,83,101],"anti-CD19":[41],"antibody":[42],"linked":[43],"via":[44],"sulfo-SPDB":[45],"DNA-alkylating":[49],"agent":[50],"DGN462.":[51],"huB4-DGN462":[52,94,115],"had":[53],"improved":[54],"in":[55,84,123],"vitro":[56,85],"anti-proliferative":[57],"and":[58,68],"activity":[60],"compared":[61],"across":[64],"multiple":[65],"B-cell":[66,90,126],"lymphoma":[67,79,91,111],"human":[69],"acute":[70],"lymphoblastic":[71],"leukemia":[72],"cell":[73],"lines.":[74],"In":[75,113],"vivo":[76],"experiments":[77],"using":[78],"xenografts":[80],"models":[81],"confirmed":[82],"data.":[86],"The":[87],"response":[88],"of":[89,103],"lines":[92],"was":[95],"not":[96],"correlated":[97],"with":[98,125],"CD19":[99],"expression,":[100],"presence":[102],"BCL2":[104],"or":[105,110],"MYC":[106],"translocations,":[107],"TP53":[108],"inactivation":[109],"histology.":[112],"conclusion,":[114],"is":[116],"an":[117],"attractive":[118],"candidate":[119],"for":[120],"investigation":[122],"patients":[124],"malignancies.":[127]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":3},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2019-02-21T00:00:00"}